Cargando…
Identification of transcription factor co-regulators that drive prostate cancer progression
In prostate cancer (PCa), and many other hormone-dependent cancers, there is clear evidence for distorted transcriptional control as disease driver mechanisms. Defining which transcription factor (TF) and coregulators are altered and combine to become oncogenic drivers remains a challenge, in part b...
Autores principales: | Siddappa, Manjunath, Wani, Sajad A., Long, Mark D., Leach, Damien A., Mathé, Ewy A., Bevan, Charlotte L., Campbell, Moray J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683598/ https://www.ncbi.nlm.nih.gov/pubmed/33230156 http://dx.doi.org/10.1038/s41598-020-77055-5 |
Ejemplares similares
-
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
por: Leach, Damien A, et al.
Publicado: (2022) -
Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
por: Buxton, Alison K., et al.
Publicado: (2022) -
Stromal Androgen Receptor in Prostate Cancer Development and Progression
por: Leach, Damien A., et al.
Publicado: (2017) -
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A
por: Siddappa, Manjunath, et al.
Publicado: (2023) -
The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide
por: Gray, Jaimie S., et al.
Publicado: (2023)